Episurf Medical AB

Equities

EPIS B

SE0003491562

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm Other stock markets 11:29:32 2024-04-23 am EDT			5-day change	1st Jan Change
0.37 ^SEK	-7.50%		-51.06%	-62.63%

Apr. 22	Episurf Medical Plans SEK120 Million Rights Issue	MT
Apr. 09	Episurf Medical AB Elects Jess Lonner as New Member of the Board of Directors	CI

Episurf Medical AB Announces Changes to the Nomination Committee Ahead of the AGM 2022

November 26, 2021 at 02:30 am EST

Episurf Medical AB (publ) announced changes to the Nomination Committee ahead of the AGM 2022. The new members appointed to nomination committee are as follows: Sebastian Jahreskog; Johan Wadell, representing Andra AP-fonden; and Robert Charpentier (Chairman of the Nomination Committee), representing Health Runner AB.

Latest news about Episurf Medical AB

Episurf Medical Plans SEK120 Million Rights Issue	Apr. 22	MT
Episurf Medical AB Elects Jess Lonner as New Member of the Board of Directors	Apr. 09	CI
Episurf Medical AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 09	CI
Sweden's Episurf Medical Secures New Patents in Asia, South Africa	Nov. 28	MT
Episurf Medical AB Receives Four Additional Patent Approval Notification	Nov. 28	CI
Episurf Medical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-27	CI
Episurf Medical Announces 510(k) Submission for Big Toe Implant	23-10-20	CI
Episurf Members Announces Nomination Committee for Episurf Medical's Annual General Meeting in 2024	23-10-17	CI
Episurf Medical Announces Early Clinical Results from Episealer Talus Study Presented at Scientific Congress	23-09-28	CI
Episurf Medical Announces Prospective Episealer Talus Clinical Study	23-09-13	CI
Episurf Medical's New Knee Joint Implant System Scheduled For Surgery Use in US	23-08-23	MT
Episurf Medical AB Announces First Commercial Case in the US Has Been Scheduled for Surgery	23-08-23	CI
Episurf Announces Results from the Use of Episealer Accepted for Publication in Scientific Journal	23-07-31	CI
Episurf Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-14	CI
Episurf Medical Wins Hospital Value Analysis Committee's Approval for Implant System	23-07-07	MT
Episurf Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Episurf Medical Builds US Distributor Network for Episealer Patellofemoral System	23-04-11	MT
Episurf Medical Receives Another Granted Patent in India	23-03-02	CI
Episurf Medical Receives Another Notice of Allowance from the United States Patent and Trademark Office	23-03-01	CI
Episurf Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-17	CI
Episurf Medical AB Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-17	CI
Episurf Medical AB Announces Dennis Stripe Not Stand for Re-Election as Chairman of the Board of Directors	23-02-13	CI
Episurf Medical AB Receives Notice of Allowance from the United States Patent and Trademark Office	23-02-02	CI
Episurf Medical Wins US FDA Approval for Patellofemoral Implant System	22-12-27	MT
Episurf Medical AB Receives FDA 510(k) clearance for Episealer® Patellofemoral System	22-12-24	CI

Chart Episurf Medical AB

Duration

Period

More charts

Company Profile

Episurf Medical AB is a Sweden-based medical technology company. It is engaged in the development, manufacture and marketing of implants and surgical drilling templates used in the treatment of local cartilage damage in knee joints. The Companyâs product portfolio includes the Episealer, and individually customized implant used as a cartilage replacement for early-stage patients; and Epiguide, a drill guide designed to attach to the kneeâs surface, as well as related surgical tools. The personalization of implants and instruments is based on magnetic resonance imaging (MRI) and enables less invasive treatment. The process of ordering and creation of patient-specific implants and surgical instruments is covered by software suite, microiFidelity, comprising microiClinic, microiDesign and microiManufacture. The main shareholder of the Company is Serendipity Ixora Fund AB.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-04-24 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Episurf Medical AB

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
EPISURF MEDICAL AB	-62.63%	9.8M
STRYKER CORPORATION	+11.42%	125B
SMITH & NEPHEW PLC	-8.69%	10.48B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-1.71%	8.42B
INSPIRE MEDICAL SYSTEMS, INC.	+13.34%	6.82B
GLAUKOS CORPORATION	+26.73%	4.96B
AXONICS, INC.	+6.88%	3.41B
ENOVIS CORPORATION	-0.20%	3.04B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-13.77%	2.1B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-9.83%	1.97B

Medical Devices & Implants